Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. 2007

Atsushi Sadanaga, and Hitoshi Nakashima, and Mitsuteru Akahoshi, and Kohsuke Masutani, and Katsuhisa Miyake, and Takashi Igawa, and Naonobu Sugiyama, and Hiroaki Niiro, and Mine Harada
Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

OBJECTIVE To determine whether innate receptor signals play an important role in the development of autoimmune nephritis in MRL/lpr mice, an experimental model of lupus nephritis. METHODS MyD88 is a critical adaptor that is involved in signaling pathways through all of the Toll-like receptors (TLRs) except TLR-3. We therefore generated MyD88-knockout (MyD88-KO) MRL/lpr mice and examined them for histopathologic changes in the kidneys, cumulative survival rates, extent of lymphadenopathy and splenomegaly, serum chemistry, and immunologic parameters. In addition, to define the role of the MyD88-independent pathway in autoimmune nephritis, we injected MyD88-KO MRL/lpr mice intraperitoneally with either poly(I-C) (50 or 100 microg per mouse) or phosphate buffered saline and examined them for survival as well as for histopathologic, serologic, and immunologic parameters. RESULTS In comparison with wild-type mice, MyD88-KO MRL/lpr mice exhibited a prolonged lifespan, with no apparent development of autoimmune nephritis. Their kidneys showed no glomerular cell proliferation or crescent formation, along with a drastic decrease in the mesangial matrix. Lymphadenopathy and splenomegaly were less pronounced. Serum titers of anti-double-stranded DNA (anti-dsDNA) and production of cytokines, including interferon-alpha (IFNalpha), interleukin-12 (IL-12), IL-6, and IFNgamma, in splenocytes were significantly reduced in MyD88-KO MRL/lpr mice. Interestingly, MyD88-KO MRL/lpr mice that had been treated with the MyD88-independent TLR-3 ligand poly(I-C) showed an almost complete reversion to the features of wild-type mice, demonstrating crescentic glomerulonephritis, with significant elevation of serum anti-dsDNA titers and increased cytokine production in splenocytes. CONCLUSIONS The findings indicate that both MyD88-dependent and MyD88-independent innate signals play a crucial role in the development of autoimmune nephritis in MRL/lpr mice.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007369 Interferon Inducers Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. Inducers, Interferon
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D009393 Nephritis Inflammation of any part of the KIDNEY. Nephritides
D011070 Poly I-C Interferon inducer consisting of a synthetic, mismatched double-stranded RNA. The polymer is made of one strand each of polyinosinic acid and polycytidylic acid. Poly(I-C),Poly(rI).Poly(rC),Polyinosinic-Polycytidylic Acid,Polyinosinic-Polycytidylic Acid (High MW),Polyriboinosinic-Polyribocytidylic Acid,Polyribose Inosin-Cytidil,Inosin-Cytidil, Polyribose,Poly I C,Polyinosinic Polycytidylic Acid,Polyriboinosinic Polyribocytidylic Acid,Polyribose Inosin Cytidil
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear

Related Publications

Atsushi Sadanaga, and Hitoshi Nakashima, and Mitsuteru Akahoshi, and Kohsuke Masutani, and Katsuhisa Miyake, and Takashi Igawa, and Naonobu Sugiyama, and Hiroaki Niiro, and Mine Harada
June 2018, Journal of immunology (Baltimore, Md. : 1950),
Atsushi Sadanaga, and Hitoshi Nakashima, and Mitsuteru Akahoshi, and Kohsuke Masutani, and Katsuhisa Miyake, and Takashi Igawa, and Naonobu Sugiyama, and Hiroaki Niiro, and Mine Harada
September 1987, Brain, behavior, and immunity,
Atsushi Sadanaga, and Hitoshi Nakashima, and Mitsuteru Akahoshi, and Kohsuke Masutani, and Katsuhisa Miyake, and Takashi Igawa, and Naonobu Sugiyama, and Hiroaki Niiro, and Mine Harada
June 2007, Journal of immunology (Baltimore, Md. : 1950),
Atsushi Sadanaga, and Hitoshi Nakashima, and Mitsuteru Akahoshi, and Kohsuke Masutani, and Katsuhisa Miyake, and Takashi Igawa, and Naonobu Sugiyama, and Hiroaki Niiro, and Mine Harada
June 1995, Lupus,
Atsushi Sadanaga, and Hitoshi Nakashima, and Mitsuteru Akahoshi, and Kohsuke Masutani, and Katsuhisa Miyake, and Takashi Igawa, and Naonobu Sugiyama, and Hiroaki Niiro, and Mine Harada
April 2011, Arthritis and rheumatism,
Atsushi Sadanaga, and Hitoshi Nakashima, and Mitsuteru Akahoshi, and Kohsuke Masutani, and Katsuhisa Miyake, and Takashi Igawa, and Naonobu Sugiyama, and Hiroaki Niiro, and Mine Harada
January 1999, Research communications in molecular pathology and pharmacology,
Atsushi Sadanaga, and Hitoshi Nakashima, and Mitsuteru Akahoshi, and Kohsuke Masutani, and Katsuhisa Miyake, and Takashi Igawa, and Naonobu Sugiyama, and Hiroaki Niiro, and Mine Harada
April 1994, The Journal of experimental medicine,
Atsushi Sadanaga, and Hitoshi Nakashima, and Mitsuteru Akahoshi, and Kohsuke Masutani, and Katsuhisa Miyake, and Takashi Igawa, and Naonobu Sugiyama, and Hiroaki Niiro, and Mine Harada
September 1994, Physiology & behavior,
Atsushi Sadanaga, and Hitoshi Nakashima, and Mitsuteru Akahoshi, and Kohsuke Masutani, and Katsuhisa Miyake, and Takashi Igawa, and Naonobu Sugiyama, and Hiroaki Niiro, and Mine Harada
July 2017, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Atsushi Sadanaga, and Hitoshi Nakashima, and Mitsuteru Akahoshi, and Kohsuke Masutani, and Katsuhisa Miyake, and Takashi Igawa, and Naonobu Sugiyama, and Hiroaki Niiro, and Mine Harada
March 1987, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!